Medical decision-making capacity in patients with malignant glioma

Neurology

Volumn 73, Issue 24, 2009, Pages 2086-2092

  Triebel, Kristen L ^a   Martin, Roy C ^a   Nabors, Louis B ^b,c   Marson, Daniel C ^a  

^a Department of Neurology   (United States)

^b Department of Neurology

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; MEDICAL DECISION MAKING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; RADIATION DOSE; SEMANTIC MEMORY; VERBAL MEMORY;

EID: 73349094370     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181c67bce     Document Type: Article

References (26)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for gli-oblastoma. N Engl J Med 2005;352:987-996.
2. Meyers CA, Hess KR. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol 2003;5:89-95.
3. Brazil L, Thomas R, Laing R, et al. Verbally administered Barthel Index as functional assessment in brain tumour patients. J Neurooncol 1997;34:187-192.
4. Remer S, Murphy ME. The challenges of long-term treatment outcomes in adults with malignant gliomas. Clin J Oncol Nurs Aug 2004;8:368-376.
5. Meyers CA, Brown PD. Role and relevance of neurocogni-tive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 2006;24:1305-1309.
6. Roth L, Meisel A, Lidz C. Tests of competency to consent to treatment. Am J Psychiatry 1977;134:279-284.
7. Appelbaum P, Grisso T. Assessing patients' capacities to consent to treatment. N Engl J Med 1988;319:1635-1638.
8. Marson D, Ingram K. Competency to consent to treatment: a growing field of research. J Ethics Law Aging 1996;2:59-63.
9. Grisso T, Appelbaum P. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. New York: Oxford University Press; 1998.
10. Berg JW, Appelbaum P, Lidz C, Parker L. Informed Consent: Legal Theory and Clinical Practice, 2nd ed. New York: Oxford University Press; 2001.
11. Okonkwo O, Griffith HR, Belue K, et al. Medical decision-making capacity in patients with mild cognitive impairment. Neurology 2007;69:1528-1535.
12. Marson DC, Ingram KK, Cody HA, Harrell LE. Assessing the competency of patients with Alzheimer's disease under different legal standards. Arch Neurol 1995;52:949-954.
13. Dymek MP, Marson DC, Harrell L. Factor structure of capacity to consent to medical treatment in patients with Alzheimer's disease: an exploratory study. J Forensic Neu-ropsychol 1999;1:27-48.
14. Lezak M, Howieson D, Loring D. Neuropsychological Assessment, 4th ed. New York: Oxford University Press; 2004.
15. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
16. Marson D. Loss of competency in Alzheimer's disease: conceptual and psychometric approaches. Int J Law Psychiatry 2001;8:109-119.
17. Dymek M, Atchison P, Harrell L, Marson D. Competency to consent to treatment in cognitively impaired patients with Parkinson's disease. Neurology 2001;56:17-24.
18. Martin R, Okonkwo O, Hill J, et al. Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia. Mov Disord 2008;23: 1867-1874.
19. Strauss E, Sherman E, Spreen O. A Compendium of Neu-ropsychological Tests, 3rd ed. New York: Oxford University Press; 2006.
20. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16: 2522-2527.
21. DeAngelis LM. Brain tumors. N Engl J Med 2001;344: 114-123.
22. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 2003;9:967-982.
23. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol 2004;3:159-168.
24. Dymek MP, Atchison P, Harrell L, Marson DC. Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease. Neurology 2001; 56:17-24.
25. Okonkwo OC, Griffith HR, Belue K, et al. Cognitive models of medical decision-making capacity in patients with mild cognitive impairment. J Int Neuropsychol Soc Mar 2008;14:297-308.
26. Palmer BW, Savla GN. The association of specific neuro-psychological deficits with capacity to consent to research or treatment. J Int Neuropsychol Soc Nov 2007;13:1047-1059.